AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Positive Trial Results For Intraocular Drug Delivery.(Brief Article)

Vaccine Weekly

| January 23, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JAN 23 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., announced results of a preclinical trial demonstrating the effectiveness of its calcium phosphate nanoparticulate (CAP) delivery system for the administration of drugs into the eye.

The results were presented December 20, 2001, at the sixth U.S.-Japan Symposium on Drug Delivery in Hawaii, cosponsored by the Massachusetts Institute of Technology, Kyoto University, Controlled Release Society, Inc., and the Japanese Society of Drug Delivery Systems.

In the study, a dopamine D3 receptor agonist, known as 7-hydroxy-dipropyl-aminotetralin (7-OH-DPAT), was combined with CAP in a proprietary formulation prepared by scientists at BioSante's research center in Smyrna, Georgia, and therapeutic efficacy was tested in two types of rabbits. The study was designed to test the effects of CAP on the ability of 7-OH-DPAT to decrease intraocular pressure (IOP), a major risk factor of glaucoma in humans.

Results showed that the addition of CAP to 7-OH-DPAT resulted in significant extension of the IOP lowering effect of the drug in New Zealand White rabbits, compared to the same amount of drug without CAP. In Dutch Belted rabbits, which have pigmented eyes, the ...

Related articles from newspapers, magazines, journals, and more
BioSante Pharmaceuticals Announces Subcontract with the University of...
Press release article from: Business Wire February 6, 2006 700+ words
...further validation for our CaP program, and allows us another avenue to use CaP to develop alternative treatment...phosphate nanotechnology (CaP) for novel vaccines, including...as anthrax and ricin, and drug delivery systems. Additional information...
The Wall Street Transcript Publishes Emerging Pharma & Drug Delivery Industry...
Press release article from: PR Newswire December 13, 1999 700+ words
...Pharmaceutical & Drug Delivery sector in the latest...Pharmaceuticals & Drug Delivery -- In an in-depth...oriented companies, drug delivery companies, generic companies...had been such a large cap bias to the market...
Drug delivery tech keeps moving into med-tech sector.
Magazine article from: Biomedical Business & Technology Berg, Jeffery January 1, 2008 700+ words
...The use of proprietary drug delivery technologies figured...effects. Oral and buccal drug delivery Durect (Cupertino...utilize its proprietary drug delivery platform technologies...uses its Oradur gel-cap for the oral delivery...
R.P. Scherer completes acquisition of U.K. drug delivery company. (Polysystems...
Press release article from: PR Newswire December 19, 1990 700+ words
...ACQUISITION OF U.K. DRUG DELIVERY COMPANY TROY, Mich...the PULSINCAP(TM) drug delivery system. Polysystems...novel patentable oral drug delivery system, which is entirely...and a water-soluble cap. The drug formulation...
Microfluidics: an opportunity for trend-setting drug delivery: microfluidics...
Magazine article from: Medical Device Technology Goettsche, T. Ernst, H. Messner, S. Sandmaier, H. March 1, 2004 700+ words
...micro fluidic systems for drug delivery. Promising discrete systems...opened using a "fuse" cap on each reservoir (see Figure 2). Each cap can be destroyed by an electrical...continuous systems Continuous drug delivery systems are commonly employed...
SkyePharma Licenses Dermatology Technology - Technology Broadens SkyePharma's...
Press release article from: PR Newswire January 8, 2001 700+ words
...manufactures advanced drug delivery solutions. Its technologies...control, generics and drug delivery. Bioglan's product...in the areas of both drug delivery and product licensing...member of the FTSE mid-cap 250 and of techMARK 100...
Reports summarize drug delivery science and technology study results from...
Newspaper article from: Drug Week May 8, 2009 700+ words
...writing in the Journal of Drug Delivery Science and Technology report (see also Drug Delivery Science and Technology...Furthermore, treatment of Cap-Na, an enhancer of...study in the Journal of Drug Delivery Science and Technology...
Medi-Ject Corporation and Permatec Holding AG Announce Agreement to Combine...
Press release article from: PR Newswire July 17, 2000 700+ words
...development of competing drug delivery systems, management...free, jet injection, drug delivery systems. Medi-Ject...traded on the Nasdaq Small Cap Market under the symbol...transdermal and transmucosal drug delivery company, originally...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA